-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Centralized management of clinical trial feasibility requests: a single center database analysis from 2008 to 2015
Dorothee Arenz, Timo Siepmann and Oliver A Cornely
Research Paper: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Monitoring randomized clinical trials in Africa; pragmatic approaches and experiences from HIV trials
Margaret J Thomason, Moira J Spyer1, Nicola Joffe1, Justine Boles, Andy Burke, Helen C Wilkes & Mary Rauchenberger
Clinical Trail Perspective: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Recent clinical evidence for topical mechlorethamine in mycosis fungoides
Joya Sahu, Marjan Sepassi, Mitchell Nagao & Youn H Kim
Clinical Trail Outcomes: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Developing a consortium for ALS clinical research: the Canadian ALS Research Network
Lorne Zinman, Angela Genge,Denise A Figlewicz
Research Update: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Evidence from clinical trials for the use of valproic acid in solid tumors: focus on prostate cancer
Jatinder Goyal, Ronald Rodriguez
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Ixabepilone and eribulin mesylate: two novel agents approved for the chemotherapeutic treatment ofmetastatic breast cancer
Yael S Zack, Linda T Vahdat
Review: Clinical Trail Outcomes: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Rationale and study design of ARCHER: a randomized, double-blind, Phase III study of dacomitinib versus erlotinib for advanced non-small-cell lung cancer
Michael Boyer, Pasi Antero Janne, Tony Mok, Kenneth OByrne, Luis Paz-Ares, Suresh S Ramalingam, Jane Liang, Ian Taylor, Alicyn Campbell, Joseph OConnell, Stephen Letrent, Vladan Antic
Methodology: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Poly(ADP-ribose) polymerase inhibitors in breast cancer and other tumors: advances and challenges
Mustafa Khasraw, Mark Robson
Review Article: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Why are epilepsy trials failing? Interview with Russell Katz
Russell Katz
Interview: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation
-
Endocrine therapy for prostate cancer: review of the latest clinical evidence
Che-Kai Tsao, Sonia Seng, William K Oh Matthew D Galsky
Review Article: Clinical Investigation